Asterias Biotherapeutics, Inc. 4
4 · Asterias Biotherapeutics, Inc. · Filed Oct 11, 2016
Insider Transaction Report
Form 4
Spink Katharine E.
Vice President & COO
Transactions
- Tax Payment
Common Stock
2016-10-06−2,878→ 4,781 total - Sale
Common Stock
2016-10-06$4.11/sh−4,781$19,635→ 0 total
Footnotes (4)
- [F1]Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 7,659 Restricted Stock Units, the grant of which was previously reported on a Form 4.
- [F2]Excludes 7,658 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report.
- [F3]The shares sold were sold pursuant to a Rule 10b5-1 Plan adopted by the reporting person.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.05 to $4.15, inclusive. The reporting person undertakes to provide to any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.